SARS_CoV_2 mutation literature information.


  Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach.
 PMID: 34307771       2021       Virusdisease
Table: P26S


  Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.
 PMID: 33664494       2021       Nature medicine
Method: Amino acid substitutions for B.1.1.7, P.1 (Brazilian lineage: L18F, T20N,
Result: Given these results with viruses encoding E484K mutations, we performed separate studies with human convalescent serum (n =10) and a chimeric SARS-CoV-2 WA1/2020 strain encoding a Brazilian variant spike gene (Wash BR-B.1.1.248; L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, and V1176F [Extended Data Fig 5a]).


  Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil.
 PMID: 33688664       2021       medRxiv
Introduction: Lineage P.1 contains 10 new amino acid mutations in the virus spike protein (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, H655Y, T1027I) compared its immediate ancestor (B.1.1.28).


  Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.
 PMID: 33724631       2021       Reviews in medical virology
Table: P26S


  Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
 PMID: 33730597       2021       Cell
Result: Although P.1 does not harbor NTD deletions, the changes L18F, T20N, and P26S would be expected to impact markedly on binding at the NTD epitope.


  Antibody evasion by the P.1 strain of SARS-CoV-2.
 PMID: 33852911       2021       Cell
Result: Although P.1 does not harbor deletions in the NTD like B.1.1.7 (Delta69-70,Delta144) or B.1.351 (Delta242-244), it is clear that the NTD mutations in P.1 (L18F, T20N, P26S, D138Y, and R190S) disrupt the epitope for mAb159 (Figure 4A).
Result: Compared to the Wuhan sequence, P.1 contains the following mutations: L18F, T20N, P26S, D138Y, and R190S in the NTD; K417T, E484K, and N501Y in the RBD; D614G and H655Y at the C terminus o


  Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.
 PMID: 33853970       2021       Science (New York, N.Y.)
Introduction: Lineage P.1 contains 10 lineage-defining amino acid mutations in the virus spike protein (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, H655Y, and T1027I) compared with its immediate ancestor (B.1.1.28).


  A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.
 PMID: 33919314       2021       Viruses
Introduction: The VOC P.1, first described in January 2021, displayed an unusual number of lineage-defining mutations in the S protein (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, H655Y, T1027I) and its emergence was associated with a second COVID-19 epidemic wave in the Amazonas state.


  Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.
 PMID: 33925854       2021       Microorganisms
Result: The BR-VOC is highly mutated in the S-gene resulting in 12 aa substitutions in the S-protein including L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, and V1176F.


  E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.
 PMID: 34044192       2021       Infection, genetics and evolution
Result: For these residues under adaptive pressure, six are included in known mutation sites of spike protein, including E484K (L5F, S12F, P26S, D138Y, A688V).
Result: Regarding the lineage-defining mutations from P.1 lineages, 14 of a total of 19 genomes from the Amazonas monophyletic group present the spike mutations L18F, T20N, P26S, D138Y, and R190S.
Table: P26S



Browser Board

 Co-occurred Entities




   Filtrator